Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we describe the Ago2-miRNA-co-IP assay designed to quantify an active pool of specific miRNAs induced by TGF-β1 in human bronchial epithelial CFBE41o- cells. This assay provides functional information on the recruitment of miRNA to the RNA induced silencing complex, quantified by qRT-PCR using specific miRNA primers and TaqMan hydrolysis probes.

Abstract

Micro(mi)RNAs are short, non-coding RNAs that mediate the RNA interference (RNAi) by post-transcriptional mechanisms. Specific miRNAs are recruited to the cytoplasmic RNA induced silencing complex (RISC). Argonaute2 (Ago2), an essential component of RISC, facilitates binding of miRNA to the target-site on mRNA, followed by cleaving the miRNA-mRNA duplex with its endonuclease activity. RNAi is mediated by a specific pool of miRNAs recruited to RISC, and thus is referred to as the functional pool. The cellular levels of many miRNAs are affected by the cytokine Transforming Growth Factor-β1 (TGF-β1). However, little is known about whether the TGF-β1 affects the functional pools of these miRNAs. The Ago2-miRNA-co-IP assay, discussed in this manuscript, is designed to examine effects of TGF-β1 on the recruitment of miRNAs to RISC and it helps to determine whether changes in the cellular miRNA levels correlate with changes in the RISC-associated, functional pools. The general principles of the assay are as follows. Cultured cells treated with TGF-β1 or vehicle control are lysed and the endogenous Ago2 is immunoprecipitated with immobilized anti-Ago2 antibody, and the active miRNAs complexed with Ago2 are isolated with a RISC immunoprecipitation (RIP) assay kit. The miRNAs are identified with quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) using miRNA-specific stem-looped primers during reverse transcription, followed by PCR using miRNA-specific forward and reverse primers, and TaqMan hydrolysis probes.

Introduction

Transforming Growth Factor-β1 (TGF-β1) is a multifunctional cytokine that can change the expression of many micro(mi)RNAs1,2,3. The total cellular level of a particular miRNA does not correlate with its inhibitory potential because only a specific fraction of the miRNA is incorporated into RNA induced silencing complex (RISC) to perform RNA interference (RNAi)3. Only up to 10% of each miRNA is RISC-associated and participates in RNAi4,5. Next, the RNAi process involves binding of the ....

Protocol

1. Preparation before experiment

  1. Seeding cells
    1. Prepare 10% collagen I solution in Minimal Essential Medium (MEM) and add 500 µL to each 24 mm cell culture filter in a 6-well plate. Distribute to cover the entire surface of the filter by rotating gently by hand. Incubate filters under the UV light in the laminar flow hood at room temperature for 30 minutes (min), followed by incubation in cell culture incubator at 37 °C for 1 h.
    2. Prepare cell culture medium (MEM.......

Representative Results

We have previously shown that TGF-β1 increased the total cellular levels of miR-145-5p, miR-143-5p, and miR-154-5p miRNAs in CFBE41o- cells3. Next, we employed the Ago2-miRNA-co-IP assay to elucidate the functional effects of TGF-β1 on these miRNAs. The RISC recruitment of miR-145-5p, miR-143-5p, and miR-154-5p was studied in CFBE41o- cells stably expressing the wild type (WT)-cystic fibrosis transmembrane conductance regulator (CFTR) or mutant CFTR with the deletion of phenylalanin.......

Discussion

The Ago2-miRNA-co-IP assay is designed to investigate the active pool of miRNAs in response to TGF-β1 treatment. The active or RISC-associated miRNAs are important to understand their inhibitory potential for the target mRNA4. Panshin et al. recently showed that the immunoprecipitation efficiency of Ago2 and miRNAs may depend on the protocol16. There are several differences between the protocol here and the above published data. The protocol here was optimized for CFBE.......

Acknowledgements

We thank John Wakefield from Tranzyme, Inc. (Birmingham, AL) who generated the CFBE41o- cells, and J.P. Clancy from the CFFT who provided the cells. This research was funded by the National Institutes of Health grants R01HL144539 and R56HL127202 (to A.S.-U.), and the Cystic Fibrosis Foundation grant SWIATE18G0.

....

Materials

NameCompanyCatalog NumberComments
100 mM dNTPs (with dTTPs)Applied Biosystems4366596
10x Reverse Transcription Buffer (RT Buffer)Applied Biosystems4366596
2-propanolFisher BioReagentsBP2618-1
2x Laemmli Sample BufferBio-Rad1610737
7300 Real Time PCR SystemApplied Biosystems4345240
Anti-Ago2 antibody (anti-EIF2C2), mouse monoclonal against human Ago2Medical & Biological Laboratories Co. LtdRN003M
Bovine Albumin Fraction V (7.5% solution)Thermo Scientific15260037
Collagen I (Purecol-Type I Bovie collagen solution)Advanced Biometrix50005-100mL
DL-Dithiothreitol (DTT)Sigma646563-.5ML
DTTSigma-Aldrich646563
EthanolDeacon Laboratories64175
Fetal Bovine SerumATLANTA BiologicalsS10350
Goat Anti-Mouse IgGBio-Rad1706516
L-glutamine (200 mM Solution; 29.20 mg/mL)Corning25-005-Cl
Mini cell scrapers United BiosystemsThermo FisherMCS-200
Minimal Essential MediumThermo Fisher Scientific11095-080
miRNA specific stem looped RT primersApplied Biosystems4427975
Mouse IgG2 controlDako, Glostrup, DenmarkA0424
MultiScribe Reverse Transcriptase, 50 U/µLApplied Biosystems4366596
Nano Drop ND-1000 SpectrophotometerNanoDrop Technologies, Inc.E112352
Nuclease-free waterAmbionAM9937
Opti-MEM (1x) Reduced Serum MediumGibco by Life Technologies11058-021
PBSGibco14190250
Penicillin-streptomycin, SterileSigma-AldrichP0781
Pierce Protease Inhibitor Tablets, EDTA-FreeThermo ScientificA32955
Protein G agarose beads (Pierce Protein G Plus Agarose)Thermo Scientific22851
PuromycinInvivoGenant-pr-1
RiboCluster Profiler RIP-Assay Kit for microRNAMedical & Biological Laboratories Co. LtdRN1005
RNase Inhibitor, 20 U/µLApplied Biosystems4366596
TaqMan 2x Universal PCR master mix without AmpErase UNGApplied Biosystems4427975
TaqMan miRNA single tube Assay (20x) containing miRNA specific forward/reverse primers and probeApplied Biosystems4427975 (assay ID #002278, #002146, and #000477)
TGF-beta1SigmaT1654
Transwell filters (24 mm)Corning Life Sciences Plastic3412
Veriti 96 Well Thermal Cycler (Model:9902)Applied Biosystems4375786

References

  1. Boguslawska, J., Kryst, P., Poletajew, S., Piekielko-Witkowska, A. TGF-beta and microRNA Interplay in Genitourinary Cancers. Cells. 8 (12), (2019).
  2. Oglesby, I. K., Chotirmall, S. H., McElvaney, N. G., Greene, C. M.

Explore More Articles

Ago2MiRNARISCTGF 1RNA InterferenceAgo2 miRNA co IP AssayQRT PCRCFBE Cells

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved